227 related articles for article (PubMed ID: 15496647)
1. Oxcarbazepine pharmacokinetics and tolerability in children with inadequately controlled epilepsy.
Rey E; Bulteau C; Motte J; Tran A; Sturm Y; D'Souza J; Markabi S; Pons G; Dulac O
J Clin Pharmacol; 2004 Nov; 44(11):1290-300. PubMed ID: 15496647
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of oral loading of oxcarbazepine suspension in selected patients with epilepsy.
Kim DW; Gu N; Lee H; Jang IJ; Chu K; Yu KS; Cho JY; Yoon SH; Na HJ; Lee SK
Int J Clin Pharmacol Ther; 2013 Oct; 51(10):780-6. PubMed ID: 23849326
[TBL] [Abstract][Full Text] [Related]
3. Oxcarbazepine in infants and young children with partial seizures.
Northam RS; Hernandez AW; Litzinger MJ; Minecan DN; Glauser TA; Mangat S; Zheng C; Souppart C; Sturm Y
Pediatr Neurol; 2005 Nov; 33(5):337-44. PubMed ID: 16243221
[TBL] [Abstract][Full Text] [Related]
4. Lack of pharmacokinetic interaction between oxcarbazepine and lamotrigine.
Theis JG; Sidhu J; Palmer J; Job S; Bullman J; Ascher J
Neuropsychopharmacology; 2005 Dec; 30(12):2269-74. PubMed ID: 16052246
[TBL] [Abstract][Full Text] [Related]
5. Efficacy, tolerability, and pharmacokinetics of oxcarbazepine oral loading in patients with epilepsy.
Kim DW; Gu N; Jang IJ; Chu K; Yu KS; Cho JY; Yoon SH; Kim HS; Oh J; Lee SK
Epilepsia; 2012 Jan; 53(1):e9-12. PubMed ID: 22091603
[TBL] [Abstract][Full Text] [Related]
6. Population pharmacokinetics of oxcarbazepine and its monohydroxy derivative in epileptic children.
Rodrigues C; Chiron C; Rey E; Dulac O; Comets E; Pons G; Jullien V
Br J Clin Pharmacol; 2017 Dec; 83(12):2695-2708. PubMed ID: 28771787
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic variability of four newer antiepileptic drugs, lamotrigine, levetiracetam, oxcarbazepine, and topiramate: a comparison of the impact of age and comedication.
Johannessen Landmark C; Baftiu A; Tysse I; Valsø B; Larsson PG; Rytter E; Johannessen SI
Ther Drug Monit; 2012 Aug; 34(4):440-5. PubMed ID: 22777154
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic drug interactions in children taking oxcarbazepine.
Sallas WM; Milosavljev S; D'souza J; Hossain M
Clin Pharmacol Ther; 2003 Aug; 74(2):138-49. PubMed ID: 12891224
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics, efficacy, and tolerability of eslicarbazepine acetate in children and adolescents with epilepsy.
Almeida L; Minciu I; Nunes T; Butoianu N; Falcão A; Magureanu SA; Soares-da-Silva P
J Clin Pharmacol; 2008 Aug; 48(8):966-77. PubMed ID: 18508949
[TBL] [Abstract][Full Text] [Related]
10. Oxcarbazepine adjunctive therapy in infants and young children with partial seizures.
Piña-Garza JE; Espinoza R; Nordli D; Bennett DA; Spirito S; Stites TE; Tang D; Sturm Y
Neurology; 2005 Nov; 65(9):1370-5. PubMed ID: 16275822
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of the monohydroxy derivative of oxcarbazepine and its enantiomers after a single intravenous dose given as racemate compared with a single oral dose of oxcarbazepine.
Flesch G; Czendlik C; Renard D; Lloyd P
Drug Metab Dispos; 2011 Jun; 39(6):1103-10. PubMed ID: 21389120
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and tolerability of eslicarbazepine acetate and oxcarbazepine at steady state in healthy volunteers.
Elger C; Bialer M; Falcão A; Vaz-da-Silva M; Nunes T; Almeida L; Soares-da-Silva P
Epilepsia; 2013 Aug; 54(8):1453-61. PubMed ID: 23758485
[TBL] [Abstract][Full Text] [Related]
13. A double-blind, placebo-controlled interaction study between oxcarbazepine and carbamazepine, sodium valproate and phenytoin in epileptic patients.
McKee PJ; Blacklaw J; Forrest G; Gillham RA; Walker SM; Connelly D; Brodie MJ
Br J Clin Pharmacol; 1994 Jan; 37(1):27-32. PubMed ID: 8148215
[TBL] [Abstract][Full Text] [Related]
14. Oxcarbazepine-induced hyponatremia and the regulation of serum sodium after replacing carbamazepine with oxcarbazepine in children.
Holtmann M; Krause M; Opp J; Tokarzewski M; Korn-Merker E; Boenigk HE
Neuropediatrics; 2002 Dec; 33(6):298-300. PubMed ID: 12571784
[TBL] [Abstract][Full Text] [Related]
15. Oxcarbazepine: preliminary clinical and pharmacokinetic studies on a new anticonvulsant.
Hooper WD; Dickinson RG; Dunstan PR; Pendlebury SC; Eadie MJ
Clin Exp Neurol; 1987; 24():105-12. PubMed ID: 3268334
[TBL] [Abstract][Full Text] [Related]
16. Long-term safety and tolerability of oxcarbazepine in children: a review of clinical experience.
Bourgeois BF; D'Souza J
Epilepsy Behav; 2005 Nov; 7(3):375-82. PubMed ID: 16176888
[TBL] [Abstract][Full Text] [Related]
17. Oxcarbazepine therapy in very young children: a single-center clinical experience.
Kothare SV; Mostofi N; Khurana DS; Mohsem B; Melvin JJ; Hardison HH; Valencia I; Legido A
Pediatr Neurol; 2006 Sep; 35(3):173-6. PubMed ID: 16939855
[TBL] [Abstract][Full Text] [Related]
18. Drug interaction and pharmacokinetic modeling of oxcarbazepine in korean patients with epilepsy.
Park KJ; Kim JR; Joo EY; Seo DW; Hong SB; Ko JW; Kim SR; Huh W; Lee SY
Clin Neuropharmacol; 2012; 35(1):40-4. PubMed ID: 22246398
[TBL] [Abstract][Full Text] [Related]
19. Parent drug and/or metabolite? Which of them is most appropriate to establish bioequivalence of two oral oxcarbazepine formulations in healthy volunteers?
Di Girolamo G; Opezzo JA; Schere D; Gonzalez CD; Moncalvo JJ
Expert Opin Pharmacother; 2007 Jul; 8(10):1415-23. PubMed ID: 17661724
[TBL] [Abstract][Full Text] [Related]
20. Relative bioavailability, metabolism and tolerability of rectally administered oxcarbazepine suspension.
Clemens PL; Cloyd JC; Kriel RL; Remmel RP
Clin Drug Investig; 2007; 27(4):243-50. PubMed ID: 17358096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]